Company Sensorion

Equities

ALSEN

FR0012596468

Biotechnology & Medical Research

Market Closed - Euronext Paris 12:35:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.769 EUR +2.26% Intraday chart for Sensorion -2.04% +78.84%

Business Summary

Sensorion is a clinical-stage biotech company, that specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, a significant global unmet medical need.

Sensorion has built a R&D technology platform to expand its understanding of the pathophysiology and etiology of inner ear related diseases, enabling it to select the best targets and modalities for drug candidates.

Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a proof of concept (PoC) clinical study in cisplatin-induced ototoxicity (CIO) and, with partner Cochlear Ltd, in a study in patients scheduled for cochlear implantation.

Sensorion has entered into a strategic collaboration with Institut Pasteur. It has two gene therapy programs, at preclinical stage, aimed at correcting hereditary forms of deafness including deafness caused by a mutation of the gene encoding for Otoferlin, and hearing loss related to mutation in GJB2 gene.

Number of employees: 57

Managers

Managers TitleAgeSince
Chief Executive Officer 45 17-04-11
Chief Tech/Sci/R&D Officer - Dec. 10
Chief Tech/Sci/R&D Officer - 20-02-17
Investor Relations Contact - -
Corporate Officer/Principal - -
General Counsel - 20-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -
Chairman 59 -
Director/Board Member 59 19-08-31
Director/Board Member 51 -
Director/Board Member - 15-03-08
Director/Board Member 56 22-01-02
Director/Board Member - -
Chief Executive Officer 45 17-04-11
Director/Board Member 50 Jan. 23
Director/Board Member 34 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 187,080,794 79,138,558 ( 42.30 %) 0 42.30 %

Shareholders

NameEquities%Valuation
Invus Public Equities Advisors LLC
9.609 %
26,490,415 9.609 % 26 M €
Sofinnova Partners SAS
5.611 %
15,469,458 5.611 % 15 M €
5,249,608 1.904 % 5 M €
3SBIO INC.
1.471 %
4,055,150 1.471 % 4 M €
BPIFrance Investissement SAS
1.270 %
3,499,874 1.270 % 3 M €
2,941,176 1.067 % 3 M €
Sofimac Innovation SAS
0.3565 %
982,911 0.3565 % 967 931 €
533,755 0.1936 % 525 621 €
SENSORION
0.0525 %
144,811 0.0525 % 142 604 €
Gestys SA
0.0102 %
28,000 0.0102 % 27 573 €

Holdings

NameEquities%Valuation
144,811 0.05% 142,604 $

Company contact information

Sensorion SA

375, rue du Professeur Joseph Blayac

34080, Montpellier

+33 4 67 20 77 30

http://www.sensorion.com
address Sensorion(ALSEN)